Invesco Ltd. Invests $803,000 in Grail, Inc. (NASDAQ:GRAL)

Invesco Ltd. acquired a new stake in Grail, Inc. (NASDAQ:GRAL - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 45,001 shares of the company's stock, valued at approximately $803,000. Invesco Ltd. owned about 0.13% of Grail as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. FNY Investment Advisers LLC acquired a new position in shares of Grail in the 4th quarter valued at about $26,000. Lindbrook Capital LLC purchased a new stake in shares of Grail during the 4th quarter worth about $28,000. Wellington Shields Capital Management LLC purchased a new stake in shares of Grail during the 4th quarter worth about $33,000. New York State Common Retirement Fund acquired a new stake in shares of Grail during the 4th quarter valued at about $59,000. Finally, Wilmington Savings Fund Society FSB purchased a new position in shares of Grail in the 4th quarter valued at about $64,000.

Grail Stock Performance

Shares of NASDAQ GRAL opened at $35.78 on Friday. The company has a 50 day simple moving average of $30.08 and a 200-day simple moving average of $25.01. Grail, Inc. has a 1 year low of $12.33 and a 1 year high of $63.99.

Grail (NASDAQ:GRAL - Get Free Report) last announced its earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, topping the consensus estimate of ($4.41) by $2.55. The company had revenue of $38.25 million for the quarter, compared to analysts' expectations of $35.33 million. On average, analysts anticipate that Grail, Inc. will post -15.15 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CEO Robert P. Ragusa sold 7,625 shares of Grail stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.21, for a total value of $237,976.25. Following the completion of the transaction, the chief executive officer now owns 828,662 shares in the company, valued at approximately $25,862,541.02. The trade was a 0.91 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, President Joshua J. Ofman sold 2,109 shares of the stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $65,800.80. Following the completion of the sale, the president now owns 559,673 shares in the company, valued at approximately $17,461,797.60. The trade was a 0.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 11,550 shares of company stock valued at $360,436.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on GRAL. Canaccord Genuity Group assumed coverage on shares of Grail in a research note on Monday, April 21st. They issued a "buy" rating and a $32.00 price target on the stock. Morgan Stanley boosted their target price on Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a report on Tuesday, March 18th.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.